Alacrity Securities files a regulatory compliance statement with BSE confirming no deviation in IPO fund usage.
The disclosure is made under SEBI Listing Regulations 32 for the quarter ended March 31, 2026.
The company states that no statement of deviation or variation in public issue proceeds is required.